RU2005113129A - METHOD FOR CARRYING OUT ANESTHESIA IN PATIENTS WITH ACUTE INTESTINAL OBSTRUCTION - Google Patents

METHOD FOR CARRYING OUT ANESTHESIA IN PATIENTS WITH ACUTE INTESTINAL OBSTRUCTION Download PDF

Info

Publication number
RU2005113129A
RU2005113129A RU2005113129/14A RU2005113129A RU2005113129A RU 2005113129 A RU2005113129 A RU 2005113129A RU 2005113129/14 A RU2005113129/14 A RU 2005113129/14A RU 2005113129 A RU2005113129 A RU 2005113129A RU 2005113129 A RU2005113129 A RU 2005113129A
Authority
RU
Russia
Prior art keywords
anesthesia
per hour
dose
blood
patients
Prior art date
Application number
RU2005113129/14A
Other languages
Russian (ru)
Inventor
Игорь Ефимович Голуб (RU)
Игорь Ефимович Голуб
Людмила Викторовна Сорокина (RU)
Людмила Викторовна Сорокина
Владимир Анатольевич Белобородов (RU)
Владимир Анатольевич Белобородов
Original Assignee
Игорь Ефимович Голуб (RU)
Игорь Ефимович Голуб
Людмила Викторовна Сорокина (RU)
Людмила Викторовна Сорокина
Владимир Анатольевич Белобородов (RU)
Владимир Анатольевич Белобородов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Игорь Ефимович Голуб (RU), Игорь Ефимович Голуб, Людмила Викторовна Сорокина (RU), Людмила Викторовна Сорокина, Владимир Анатольевич Белобородов (RU), Владимир Анатольевич Белобородов filed Critical Игорь Ефимович Голуб (RU)
Priority to RU2005113129/14A priority Critical patent/RU2005113129A/en
Publication of RU2005113129A publication Critical patent/RU2005113129A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (1)

Способ проведения наркоза у больных с острой кишечной непроходимостью путем введения лекарственных средств и проведения внутрисосудистого гелий-неонового лазерного облучения крови, отличающийся тем, что вводят 2% лидокаин в дозе 0,7 мг/кг в час в перидуральное пространство на уровне Th7-Th8 за 40 мин до хирургического вмешательства, проводят внутрисосудистое гелий-неоновое лазерное облучение крови с экспозицией по 20 мин до операции, в травматичный период, перед наложением швов на операционную рану и через 24 ч после операции с экспозицией 60 мин, а вводный наркоз осуществляют введением кетамина 2,8±0,1 мг/кг, фентанила 2,7±0,1 мкг/кг в час, гамма-оксимасляной кислоты в дозе 72, 0±2,0 мг/кг, тиопентала натрия в дозе 4,0 мг/кг, для поддержания анестезии вводят фентанил 2,7±0,1 мкг/кг в час, кетамин - 2,8 мг/кг, в перидуральное пространство вводят 2% лидокаин 0,7 мг/кг в час, причем адекватность наркоза оценивают по клиническим признакам и лабораторным показателям, включающим определение в крови кортизола, диеновых конъюгатов, малонового диальдегида, антиокислительной активности плазмы, ядерного индекса интоксикации, лейкоцитарного индекса интоксикации по Каль-Калифу, которые определяют перед операцией, в травматичный период операции, после окончания операции и наркоза и через 24 ч после операции.A method for anesthesia in patients with acute intestinal obstruction by administering drugs and intravascular helium-neon laser irradiation of blood, characterized in that 2% lidocaine is administered at a dose of 0.7 mg / kg per hour into the epidural space at a Th7-Th8 level per 40 min before surgery, intravascular helium-neon laser blood irradiation is performed with an exposure of 20 minutes before surgery, in the traumatic period, before suturing the surgical wound and 24 hours after surgery with an exposure of 60 mi and induction anesthesia is carried out by the introduction of ketamine 2.8 ± 0.1 mg / kg, fentanyl 2.7 ± 0.1 μg / kg per hour, gamma-hydroxybutyric acid at a dose of 72, 0 ± 2.0 mg / kg, thiopental sodium at a dose of 4.0 mg / kg, fentanyl 2.7 ± 0.1 μg / kg per hour is administered to maintain anesthesia, ketamine 2.8 mg / kg, 2% lidocaine 0.7 mg / kg is introduced into the epidural space per hour, and the adequacy of anesthesia is assessed by clinical signs and laboratory parameters, including determination of cortisol, diene conjugates, malondialdehyde, plasma antioxidant activity in the blood, nuclear index and intoxication, the leukocyte intoxication index according to Cal-Caliph, which is determined before the operation, in the traumatic period of the operation, after the operation and anesthesia, and 24 hours after the operation.
RU2005113129/14A 2005-04-29 2005-04-29 METHOD FOR CARRYING OUT ANESTHESIA IN PATIENTS WITH ACUTE INTESTINAL OBSTRUCTION RU2005113129A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2005113129/14A RU2005113129A (en) 2005-04-29 2005-04-29 METHOD FOR CARRYING OUT ANESTHESIA IN PATIENTS WITH ACUTE INTESTINAL OBSTRUCTION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2005113129/14A RU2005113129A (en) 2005-04-29 2005-04-29 METHOD FOR CARRYING OUT ANESTHESIA IN PATIENTS WITH ACUTE INTESTINAL OBSTRUCTION

Publications (1)

Publication Number Publication Date
RU2005113129A true RU2005113129A (en) 2006-11-10

Family

ID=37500518

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2005113129/14A RU2005113129A (en) 2005-04-29 2005-04-29 METHOD FOR CARRYING OUT ANESTHESIA IN PATIENTS WITH ACUTE INTESTINAL OBSTRUCTION

Country Status (1)

Country Link
RU (1) RU2005113129A (en)

Similar Documents

Publication Publication Date Title
Ge et al. Zinc attenuates ferroptosis and promotes functional recovery in contusion spinal cord injury by activating Nrf2/GPX4 defense pathway
JP6205676B2 (en) Independent analgesic sustained release drug delivery system and method for producing the same
RU2644635C2 (en) Systems, methods and compositions for cancer treatment
BR112020012586A2 (en) compositions and treatment methods for neurological disorders containing a form of dementia
RU2010129825A (en) MATERIALS AND METHODS FOR TREATMENT OF PATHOLOGICAL PROLIFERATION OF EYE VESSELS
AU2018392985A1 (en) Compositions and methods of treatment for neurological disorders comprising motor neuron diseases
JP2004532215A (en) Functional role of cannabinoids on autonomic stability during sleep
Loughran et al. Unilateral retrobulbar hematoma following maxillary nerve block in a dog
JP2011506505A (en) Medicament and its production method and use in the treatment of painful neuropathy
KR20230107890A (en) Methods and Compositions for Treating Psychotic Disorders
KR20110042108A (en) Novel methylenedioxy phenolic compounds and their use to treat disease
WO2020132378A2 (en) Compositions and methods of treatment for neurological disorders comprising depression
RU2011139015A (en) MEDICINE CAUSED LIPOATROPHY FOR COSMETIC PURPOSES
RU2005113129A (en) METHOD FOR CARRYING OUT ANESTHESIA IN PATIENTS WITH ACUTE INTESTINAL OBSTRUCTION
JP6053945B2 (en) Use of statin compounds as topical drugs to treat obesity, diabetes, hypertension and hyperlipidemia
RU2019110755A (en) SUBLINGUAL OR BUCKAL DIM FOR THE TREATMENT OF SKIN DISEASES
IL148068A (en) Use of alpha- lipoic acid or derivatives thereof as an active ingredent in the manufacture of medicaments for treating or preventing migraine
CN114159450A (en) Use of protopanoxadiol compounds in treating pain and addiction to substances physical dependence, mental dependence and addiction
RU2006133667A (en) METHOD FOR PREVENTION OF COMPLICATIONS IN COMBINED TREATMENT OF PATIENTS WITH LUNG CANCER AND STOMACH
US8975298B2 (en) Therapeutic agent for pain
RU2572504C1 (en) Method of treating radial sialadenopathy
RU2478386C1 (en) Method of performing anesthesia in experiment
RU2119805C1 (en) Method for treating encephalopaty
EP4000607A1 (en) Synergistic combination of s-ketorolac and pregabalin in a pharmaceutical composition for the treatment of neuropathic pain
RU2549940C2 (en) Using combination of angiotensin-converting enzyme inhibitor and pineal hormone for treating ischemic heart disease in elderly patients

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20061120